Targeted Radiotherapy
About us
- Team
- Contact
- Directions
News
Careers
Search
Menu Menu

Blog - Latest News

You are here: Home1 / 20222 / 3BP company statement re recent events involving Clovis Oncology and F...

22. December 2022/by Jan Michel

3BP company statement re recent events involving Clovis Oncology and FAP-2286

Share this entry

Share on Facebook
Share on Twitter
Share on Pinterest
Share on LinkedIn
Share on Tumblr
Share on Vk
Share on Reddit
Share by Mail

https://3b-pharma.com/wp/wp-content/uploads/2019/07/logo-1.png 0 0 Jan Michel https://3b-pharma.com/wp/wp-content/uploads/2019/07/logo-1.png Jan Michel2022-12-22 17:20:342022-12-22 17:21:513BP company statement re recent events involving Clovis Oncology and FAP-2286

Imprint
Data privacy statement

3B Pharmaceuticals GmbH
Magnusstraße 11
D-12489 Berlin
Tel: +49 (0)30 / 63 92 - 43 17
Fax: +49 (0)30 / 63 92 - 43 16
info@3b-pharma.com

3B Pharmaceuticals hosts industry symposium on radiopharmaceutical innovation...3B Pharmaceuticals enters into a Global Exclusive Licensing Agreement for its...

Scroll to top